1-800-GET-HAIRPhone Icon Location Icon

Dr. Lopresti is a cool, laid back guy. He’s about my age, and really understood exactly what I was going through.

Stephen Gostkowski
New England Patriots Super Bowl XLIX, LI and LIII Champion
						https://www.hairdr.com/wp-content/uploads/2018/12/scalabrine_slide-1-2.png					

Dr. Leonard to Address Global Audiences in September

CRANSTON, Rhode Island (August 18, 2011) – Dr. Robert Leonard, chief surgeon and founder of Leonard Hair Transplant Associates, will address two international gatherings of medical experts in September.

On September 15, Dr. Leonard will address the 19th Annual Scientific Meeting of the International Society of Hair Restoration Surgery, which will take place in Anchorage, Alaska, about NeoGraftTM. Leonard Hair Transplant Associates is the only hair restoration practice in New England to use NeoGraftTM, a revolutionary, automated technique which provides patients with a more efficient, less traumatic harvest of donor hair.

Among his remarks, Dr. Leonard will speak about the following:

• How the introduction of the NeoGraftTM device and procedure has affected the way in which his hair restoration practice operates, including pre- and post-operative procedures , use of medications, and staffing alterations.

On September 17, Dr. Leonard will address the AP Dermatology Summit in Shanghai, China, about the diagnosis and treatment of Androgenetic Alopecia, which is the most common form of hair loss in both men and women.

Among his remarks, Dr. Leonard will speak about the following:

• Differential diagnosis of Alopecia, including various forms of Alopecia, such as Alopecia Areata, Alopecia Universalis, Alopecia Totalis, Androgenetic Alopecia, and Traction Alopecia;

• Psychosocial Aspects of Androgenetic Alopecia, including depression and self-perception, and the effects on personal and professional relationships;

• Clinical Management of Androgenetic Alopecia in Men, including patient/physician interaction, best candidates for treatment, best treatment options, as well as benefit and safety analysis